In conclusion, our study reveals that METTL14 in microglia promotes pathological retinal neovascularization through binding with MXD1 mRNA in a YTHDF2-dependent manner, offering new therapeutic strategies and potential targets for RNV diseases including ROP. The gene discussed is MXD1; the disease is retinopathy of prematurity.